Listed in Penny Stocks, Stock Picks, StockGuru.com, Day Trading, Best Stocks

SAN DIEGO, CA–(Marketwire – Apr 28, 2011) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based therapeutics, is one of few companies invited to present at the April 29, 2011 seminar “Unmet Needs: Emerging Frontiers in Ophthalmic Science,” which was organized by the ARVO Foundation for Eye Research (AFER). ARVO (Association for Research in Vision and Ophthalmology) is the world’s largest organization of eye and vision scientists. This seminar precedes the ARVO Annual Meeting, which will be held in Ft. Lauderdale on May 1-5, 2011.

Lpath’s president and chief executive officer, Scott Pancoast, is scheduled to present on Friday, April 29 at 11:35 a.m. eastern time. He will focus on the potential of Lpath’s iSONEP™ drug candidate to provide differentiated patient benefits vis-à-vis drugs already approved for wet AMD and those in late-stage trials — and thereby fulfill unmet clinical needs. He will also touch upon the company’s plans to further investigate iSONEP in two mid-stage trials, both of which are due to begin this quarter.

Penny Stocks are stocks traded for under $2 and they represent the small cap companies. They trade on the OTCBB so you will not find them on the major stock exchanges. They are very cheap stocks and normally come for businesses needing capital. They are a very risky investment as the business can go under and leave you with a stock worth nothing. However that being said penny stock trading can be a great money maker, and there are numerous traders who make 6 figures and more from them each year.

The best reasons to trade in penny stocks are the fact that they do not require a large initial investment, meaning that they are an affordable investment for many. Penny stocks are cheap. For example if you were to buy 1000 shares in a company with shares at 10 cents, you would only require an investment of $100, whereas if the shares cost $5 you would require an investment of $5000. Penny stocks also have the potential of huge gains, and have been known to rise as much as 1000% daily. Therefore your $100 investment can be worth $1000. This is very unlikely to happen to other stocks from large cap businesses.





Article source: http://www.marketwire.com/press-release/lpath-to-present-at-arvo-investor-seminar-focused-on-unmet-clinical-needs-otcbb-lptn-1507547.htm